ArticleBMC public health2025
Productivity benefits of chronic obstructive pulmonary disease prevention in China.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAlthough COPD places a significant health and economic burden on Chinese society, its associated productivity losses among working-age adults have not been estimated at the population level.
methodsDynamic life table models, utilizing country-specific data from published literature and public datasets, estimated the gains in productivity-adjusted life-years (PALYs), and associated cost savings from preventing incident COPD among China's working-age population (20-63 years in men and 20-58 years in women) from 2021 to 2030. Productivity losses, encompassing excess mortality, reduced labor force participation, presenteeism, and absenteeism, were aggregated to determine PALYs lost. Comparing model outputs with and without COPD incidence yielded the potential benefits of prevention. To evaluate the labor saved from preventing smoking and PM
resultsFrom 2021 to 2030, the projected elimination of incident COPD among China's working-age population would yield an estimated 2.13 million PALYs gained (95% confidence interval [CI]: 1.80-2.42 million), translating to a $104.38 billion (95% CI: $88.35 - $119.03 billion) contribution to China's GDP. For both sexes, the saved productivity derived from controlling incident COPD was consistently highest within the 55-59 age bracket, and lowest within the 25-29 age bracket. Independently, achieving recommended 2030 targets for smoking prevalence and PM
conclusionsCOPD prevention extends productive life years and enhances workforce productivity across all working-age groups. Policymakers should recognize COPD's substantial impact on labor output and implement targeted interventions to mitigate these economic losses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.